Citation: Aa. Miller et al., THERAPEUTIC DRUG-MONITORING OF 21-DAY ORAL ETOPOSIDE IN PATIENTS WITHADVANCED NONSMALL CELL LUNG-CANCER, Clinical cancer research, 4(7), 1998, pp. 1705-1710
Authors:
ROBBINS KT
KUMAR P
REGINE WF
WONG FSH
WEIR AB
FLICK P
KUN LE
PALMER R
MURRAY T
FONTANESI J
FERGUSON R
THOMAS R
HARTSELL W
PAIG CU
SALAZAR G
NORFLEET L
HANCHETT CB
HARRINGTON V
NIELL HB
Citation: Kt. Robbins et al., EFFICACY OF TARGETED SUPRADOSE CISPLATIN AND CONCOMITANT RADIATION-THERAPY FOR ADVANCED HEAD AND NECK-CANCER - THE MEMPHIS EXPERIENCE, International journal of radiation oncology, biology, physics, 38(2), 1997, pp. 263-271
Authors:
NIELL HB
MILLER AA
CLAMON GH
PERRY MC
CRAWFORD J
GREEN MR
Citation: Hb. Niell et al., A PHASE-II STUDY EVALUATING THE EFFICACY OF CARBOPLATIN, ETOPOSIDE, AND PACLITAXEL WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH STAGE-IIIB AND STAGE-IV NONSMALL CELL LUNG-CANCER AND EXTENSIVE SMALL-CELL LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 130-134
Authors:
BENNETT CL
SMITH TJ
GEORGE SL
HILLNER BE
FLEISHMAN S
NIELL HB
Citation: Cl. Bennett et al., FREE-RIDING AND THE PRISONERS-DILEMMA - PROBLEMS IN FUNDING ECONOMIC-ANALYSES OF PHASE-III CANCER CLINICAL-TRIALS, Journal of clinical oncology, 13(9), 1995, pp. 2457-2463
Citation: Aa. Miller et al., PHASE-II STUDY OF PROLONGED ORAL ETOPOSIDE IN COMBINATION WITH INTRAVENOUS CISPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER, Lung cancer, 12(1-2), 1995, pp. 59-65
Citation: Hb. Niell et al., CYTOTOXIC EFFECTS OF ALPHA-INTERFERON AND GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR IN HUMAN BLADDER-TUMOR CELL-LINES, Urological research, 22(4), 1994, pp. 247-250
Authors:
MILLER AA
TOLLEY EA
NIELL HB
GRIFFIN JP
MAUER AM
Citation: Aa. Miller et al., PHARMACODYNAMICS OF PROLONGED ORAL ETOPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 11(6), 1993, pp. 1179-1188